ATXI

Avenue Therapeutics, Inc. Common Stock
ATXI

Overview Fund Activity
Delisted

ATXI was delisted on the 18th of March, 2025.

Back to rankings

6 hedge funds and large institutions have $517K invested in Avenue Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BRWA
1
B. Riley Wealth Advisors
Florida
$201K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$161K
3
VF
3
Virtu Financial
New York
$58K
4
UBS Group
4
UBS Group
Switzerland
$35K
5
BlackRock
5
BlackRock
New York
$62K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
SIM
3
Spark Investment Management
New York
$0
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BRWA
1
B. Riley Wealth Advisors
Florida
$201K 55,500 +40,500 +270%
Vanguard Group
2
Vanguard Group
Pennsylvania
$161K 44,192 +19,652 +80%
BlackRock
3
BlackRock
New York
$62K 17,065 +680 +4%
VF
4
Virtu Financial
New York
$58K 15,917 +15,917 New
UBS Group
5
UBS Group
Switzerland
$35K 9,765 +9,765 New
Millennium Management
6
Millennium Management
New York
– – -46,702 Closed
Goldman Sachs
7
Goldman Sachs
New York
– – -16,018 Closed
SIM
8
Spark Investment Management
New York
– – -12,493 Closed
TRCT
9
Tower Research Capital (TRC)
New York
– – -7,325 Closed
Morgan Stanley
10
Morgan Stanley
New York
$0 21 -775 -97%